StockClub
AIDX20/20 Biolabs Inc.$ --
20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -15.7%
Operating Income
-1M USD
YoY +21.4%
Net Income
-2M USD
YoY -9.0%
EPS
-0.28$
YoY +33.3%

Revenue

$353,375
FY2023 Q1$419,381
$419,381
Q1
FY2023 Q2$755,317
$755,317
Q2
FY2024 Q3$361,009
$361,009
Q3
FY2024 Q4$897,093
$897,093
Q4
FY2025 Q3$417,979
$417,979
Q3
FY2025 Q4$956,253
$956,253
Q4
FY2026 Q1$353,375
$353,375
Q1
Actual
$-66,006 (-15.7%)

Net Income

$-2.2M
FY2023 Q1$-2M
$-2M
Q1
FY2023 Q2$-3.7M
$-3.7M
Q2
FY2024 Q3$-1.9M
$-1.9M
Q3
FY2024 Q4$-3.1M
$-3.1M
Q4
FY2025 Q3$-825,539
$-825,539
Q3
FY2025 Q4$-2.1M
$-2.1M
Q4
FY2026 Q1$-2.2M
$-2.2M
Q1
Actual
$-180,024 (-9.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$2.3M
FY2020
$2.3M
FY2021
Actual:$9.6M
FY2021
$9.6M
FY2022
Actual:$11.1M
FY2022
$11.1M
FY2023
Actual:$1.4M
FY2023
$1.4M
FY2024
Actual:$1.8M
FY2024
$1.8M
FY2025
Actual:$2M
FY2025
$2M

Analyst Estimates

No forecast data